Bitcoin sets a new all-time high above $6,000 >>> READ MORE


Pfizer (PFE) Sell Ranking Confirmed

Pfizer Inc (NYSE:PFE) is ranked as a Sell using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking PFE has had from Portfolio Grader for the last month. More 

Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back

For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead. More 

3 Dividend Stocks to Buy and Hold Forever

Dividend and growth fanatics have argued tooth-and-nail about who backs the superior strategy for decades. But time and time again, deep research shows that inv... More 

Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear

BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support. More 

Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock

Wall Street goes on buying sprees into the biotech sector. Take advantage of this run to profit from red hot AMGN Stock. It's headed higher. More 

Pfizer Accused of Not Investigating EpiPen Failures

The U.S. Food and Drug Administration is taking Pfizer (PFE) to task for allegedly not investigating cases of EpiPen failure. More 

Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow

Gilead Sciences was the poster child of a falling knife for two years. Now, we can use a double bottom in GILD stock to generate income. More